The Winding Road to Equal Care: Attitudes and Experiences of Prescribing ADHD Medication among Pediatric Psychiatrists: A Qualitative Study
- PMID: 36612543
- PMCID: PMC9820036
- DOI: 10.3390/ijerph20010221
The Winding Road to Equal Care: Attitudes and Experiences of Prescribing ADHD Medication among Pediatric Psychiatrists: A Qualitative Study
Abstract
Evidence is lacking on how to understand the reasons for variations, both in prevalence of ADHD and ADHD medication prescribing patterns in children and adolescents, within Region Skåne. These variations are not in line with current national clinical guidelines and seem to have increased over time. This qualitative interview study illuminates pediatric psychiatrists' attitudes toward ADHD and their experiences of prescribing ADHD medication. Eleven pediatric psychiatrists described the complex interplay of variables that they experienced while assessing a child, which had influence on their decision to prescribe medication. Being part of a local unit's culture influenced how ADHD medications were prescribed. They wished that the assessment of the child's symptoms was consistent with guidelines in every unit but noted that such alignment was not implemented. They pointed out that an ADHD diagnosis is dependent on the surrounding's motivation and capacity to adapt to the present state of the child. The participants described how they balanced clinical guidelines with demands from the family, as well as from society at large. Their personal attitudes and clinical experiences towards diagnosing and prescribing medications to children with ADHD influenced their decisions. The study adds information about how attitudes may lead to variation in diagnostics and therapy.
Keywords: ADHD; child and adolescent psychiatry; parents; prescription variation; qualitative method.
Conflict of interest statement
P.G. is currently involved in a retrospective study on Melatonin treatment for insomnia in children with ADHD, funded by AGB Pharma. M.G.P. was 2018–2019 involved in a pharmaceutical trial on Dextroamphetamine in children, funded by Evolan/Medici. The other authors declare no conflict of interest.
References
-
- Franke B., Michelini G., Asherson P., Banaschewski T., Bilbow A., Buitelaar J.K., Cormand B., Faraone S.V., Ginsberg Y., Haavik J., et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur. Neuropsychopharmacol. 2018;28:1059–1088. doi: 10.1016/j.euroneuro.2018.08.001. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical